Century Therapeutics Presented New Diabetes Therapy Data
The company showcased promising nonclinical results for its iPSC-derived islet replacement therapy in Milan.
Live Poll
Should medical regulators accelerate the approval process for experimental cell therapies to treat chronic diseases?